© 2004 by European Society of Cardiology
Copyright © 2004, European Society of Cardiology
Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro
aDepartment of Obstetrics and Gynaecology, Faculty of Medicine, National University of Singapore, 5 Lower Kent Ridge Road, Singapore 119074
bDivision of Cardio-Thoracic Vascular Surgery, Department of Surgery, Faculty of Medicine, National University of Singapore, 5 Lower Kent Ridge Road, Singapore 119074
cCell and Tissue Culture Laboratory, Faculty of Dentistry, National University of Singapore, 5 Lower Kent Ridge Road, Singapore 119074
* Corresponding author. Tel.: +65-6772-4262; fax: +65-6779-4753. Email address: denhenga{at}nus.edu.sg
Most studies on stem cell transplantation therapy on myocardially infarcted animal models and phase-I human clinical trials have focused on the use of undifferentiated stem cells. There is a strong possibility that some degree of cardiomyogenic differentiation of stem cells in vitro prior to transplantation would result in higher engraftment efficiency, as well as enhanced myocardial regeneration and recovery of heart function. Additionally, this may also alleviate the probability of spontaneous differentiation of stem cells into undesired lineages and reduces the risk of teratoma formation, in the case of embryonic stem cells. The development of efficient protocols for directing the cardiomyogenic differentiation of stem cells in vitro will also provide a useful model for molecular studies and genetic manipulation. This review therefore critically examines the various techniques that could possibly be used to direct and control the cardiomyogenic differentiation of stem cells in vitro.
KEYWORDS Stem cells; Differentiation; Myocardial infarction; Cardiomyocytes; Transplantation
Time for primary review 00 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. A.J. Chamuleau, E. van Belle, and P. A. Doevendans Enhancing cardiac stem cell differentiation into cardiomyocytes Cardiovasc Res, June 1, 2009; 82(3): 385 - 387. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rajasingh, E. Bord, H. Hamada, E. Lambers, G. Qin, D. W. Losordo, and R. Kishore STAT3-Dependent Mouse Embryonic Stem Cell Differentiation Into Cardiomyocytes: Analysis of Molecular Signaling and Therapeutic Efficacy of Cardiomyocyte Precommitted mES Transplantation in a Mouse Model of Myocardial Infarction Circ. Res., October 26, 2007; 101(9): 910 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Clement, M. Stouffs, E. Bettiol, S. Kampf, K.-H. Krause, C. Chaponnier, and M. Jaconi Expression and function of {alpha}-smooth muscle actin during embryonic-stem-cell-derived cardiomyocyte differentiation J. Cell Sci., January 15, 2007; 120(2): 229 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Roura, J. Farre, C. Soler-Botija, A. Llach, L. Hove-Madsen, J. J. Cairo, F. Godia, J. Cinca, and A. Bayes-Genis Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells Eur J Heart Fail, October 1, 2006; 8(6): 555 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Agbulut, M. Mazo, C. Bressolle, M. Gutierrez, K. Azarnoush, L. Sabbah, N. Niederlander, G. Abizanda, E. J. Andreu, B. Pelacho, et al. Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium? Cardiovasc Res, October 1, 2006; 72(1): 175 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nemir, A. Croquelois, T. Pedrazzini, and F. Radtke Induction of Cardiogenesis in Embryonic Stem Cells via Downregulation of Notch1 Signaling Circ. Res., June 23, 2006; 98(12): 1471 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schmelter, B. Ateghang, S. Helmig, M. Wartenberg, and H. Sauer Embryonic stem cells utilize reactive oxygen species as transducers of mechanical strain-induced cardiovascular differentiation FASEB J, June 1, 2006; 20(8): 1182 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fukuda and S. Yuasa Stem Cells as a Source of Regenerative Cardiomyocytes Circ. Res., April 28, 2006; 98(8): 1002 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Vesely Heart Valve Tissue Engineering Circ. Res., October 14, 2005; 97(8): 743 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Haider and M. Ashraf Bone marrow stem cell transplantation for cardiac repair Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2557 - H2567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Illi, A. Scopece, S. Nanni, A. Farsetti, L. Morgante, P. Biglioli, M. C. Capogrossi, and C. Gaetano Epigenetic Histone Modification and Cardiovascular Lineage Programming in Mouse Embryonic Stem Cells Exposed to Laminar Shear Stress Circ. Res., March 18, 2005; 96(5): 501 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Garcia-Dorado, K.-D. Schluter, E. A. Martinson, and H. M. Piper Which papers are most interesting to the readers of Cardiovascular Research? Information from download monitoring Cardiovasc Res, January 1, 2005; 65(1): 1 - 5. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jankowski, B. Danalache, D. Wang, P. Bhat, F. Hajjar, M. Marcinkiewicz, J. Paquin, S. M. McCann, and J. Gutkowska Oxytocin in cardiac ontogeny PNAS, August 31, 2004; 101(35): 13074 - 13079. [Abstract] [Full Text] [PDF]
|
|